Ivoclar Vivadent, Inc.

I'll research this company before writing the profile.

Let me verify the litigation context and ownership details.

Ivoclar Vivadent, Inc. is the U.S. subsidiary of the Ivoclar Group, a privately held, family-owned dental company. The parent, Ivoclar Vivadent AG, is headquartered in Schaan, Liechtenstein; the U.S. entity's North American headquarters is at 175 Pineview Drive, Amherst, New York. The group traces its origin to 1923 in Zurich as a maker of artificial ceramic teeth, moved to Liechtenstein in the 1930s, and rebranded from "Ivoclar Vivadent" to simply Ivoclar in 2022. It remains closely held by the Zeller family trust; Forbes and Liechtenstein commercial records identify Christoph Zeller as controlling owner. Public sources put the group at roughly 3,500–3,800 employees worldwide and annual revenue in the range of about $900M–$950M; the North American team numbers over 500, with roughly 200 at Amherst. These figures come from company media material, Forbes, and third-party company profiles rather than audited filings.

Products / operations. Ivoclar manufactures and distributes dental materials and systems sold to dentists and dental laboratories in roughly 130 countries, organized around direct restoratives, fixed prosthetics, and removable prosthetics. Offerings include dental ceramics and zirconia, composite restoratives, adhesives, cements, artificial teeth and denture materials, CAD/CAM and milling materials, 3D-printing and digital denture workflows, whitening products (including VivaStyle strips), and processing equipment, plus professional education and training programs. The Amherst site handles distribution, R&D, sales/marketing, and dental education for the U.S. market.

Litigation posture. The tracked data show Ivoclar Vivadent, Inc. as a defendant in one case and plaintiff in none — a one-way posture consistent with an operating company being sued rather than a patent assertion entity. The sole tracked matter, CAO Group, Inc. v. Ivoclar Vivadent, Inc. (1:25-cv-01430, D. Del., filed Nov. 24, 2025, Judge Colm F. Connolly), asserts five patents (10,602,259; 10,646,419; 11,219,582; 11,826,444; 11,826,445) covering peroxide gel whitening-strip compositions, targeting the VivaStyle Teeth Whitening Strips. It is venued in Delaware, not a plaintiff-friendly Texas district. Stanford's NPE litigation database classifies the plaintiff, CAO Group, as a "product company," not an NPE.

Context. The single tracked U.S. case reflects a dental-materials whitening-strip dispute rather than a broad assertion campaign. Separately, press reports (JUVE Patent, via China's MOFCOM IP channel) describe Ivoclar itself enforcing dental-restoration patents in Germany against competitor Huliang Bio-Tech at the 2025 IDS trade fair; the Düsseldorf Regional Court reportedly dismissed that claim in February 2026. No merits view is taken here.